Skip to main content

Peer Review reports

From: Minocycline prevents and repairs the skin disorder associated with afatinib, one of the epidermal growth factor receptor-tyrosine kinase inhibitors for non-small cell lung cancer

Original Submission
31 Dec 2019 Submitted Original manuscript
27 Jan 2020 Reviewed Reviewer Report - Javier Camacho
2 Feb 2020 Reviewed Reviewer Report - Maria Adriana Neag
4 Mar 2020 Author responded Author comments - Kazumi Sano
17 Mar 2020 Author responded Author comments - Kazumi Sano
Resubmission - Version 2
4 Mar 2020 Submitted Manuscript version 2
20 Mar 2020 Author responded Author comments - Kazumi Sano
Resubmission - Version 3
20 Mar 2020 Submitted Manuscript version 3
25 Mar 2020 Author responded Author comments - Kazumi Sano
Resubmission - Version 4
25 Mar 2020 Submitted Manuscript version 4
Publishing
27 Mar 2020 Editorially accepted
6 Apr 2020 Article published 10.1186/s12885-020-06797-2

You can find further information about peer review here.

Back to article page